Search

In this work, we present an integrative revision of the Lymnaeidae from the northeastern margin of Asia (Far East Russia, Japan, and Korea) and Alaska. According to our results, 14 native species inhabit this region, belonging to eight genera in two subfamilies (Lymnaeinae: Dallirhytis , Galba , Walhiana , Ladislavella , and Lymnaea ; and Amphipepleinae: Kamtschaticana , Orientogalba , and Radix). Four of these species are new to science and three of them are described in this paper. Additionally, three established alien species are recorded from Japan (Pseudosuccinea columella , Galba schirazensis , and Galba humilis). The Japanese Archipelago represents an evolutionary hotspot of pond snail diversity, encompassing seven native species, three of which are endemic. The faunal connections between North America and northeastern Asia are discussed in the context of historical biotic interchange across the Beringian Land Bridge. Two cold-tolerant pond snails share high-latitude but localized ranges, being endemic to the Beringian Arctic: Dallirhytis atkaensis (Chukchi Peninsula, Alaska, and Aleutian Islands) and Walhiana arctica comb. nov. (Alaska). Our findings indicate that the Beringian Land Bridge has played a role in freshwater faunal exchanges between northeastern Asia and western North America. [ABSTRACT FROM AUTHOR]

Currently, the validity of many nominal bivalve species of the genus Corbicula endemic to the Russian Far East and South Korea needs a critical reassessment. In this study, we clarify the taxonomic status of Corbicula species of this area based on a combination of molecular genetic, conchological and anatomical data. According to our results, four Corbicula lineages, corresponding to the nominal species Corbicula japonica , Corbicula elatior , Corbicula leana and Corbicula fluminea , can be delineated in samples collected in the Primorye and Khabarovsk regions of Russia and South Korea. Two species endemic to the Russian Far East (i.e. Corbicula finitima and Corbicula lindholmi) are considered here as junior synonyms of the species C. japonica , which is widely distributed in estuarine habitats around the Japanese Archipelago, Sakhalin Island, southern Kurile Islands, Primorye and Khabarovsk regions, Korean Peninsula and China. Three nominal species described from the Lower Amur basin (Corbicula amurensis , Corbicula nevelskoyi and Corbicula sirotskii) appeared to be synonyms of C. elatior , whose range covers the Korean Peninsula, Primorye and Khabarovsk regions and, perhaps, China. We delineated several colour morphs of C. fluminea and C. japonica. The distinctness between these colour morphs can be attributed to both heritable and environmental factors. [ABSTRACT FROM AUTHOR]

Canine natural killer (NK) cells are large, granular lymphocytes that are neither B lymphocytes nor T lymphocytes. However, it has been reported that canine NK cells share some of the phenotypic characteristics of T lymphocytes, such as CD3 and CD5. Studies are needed to assess the safety of canine NK cells for immunotherapy, especially because the safety of using allogeneic NK cells as an immunotherapy for dogs has yet to be shown. In this study, the safety of cultured canine NK cells was assessed using a xenogeneic mouse model of graft‐versus‐host disease (GVHD). Mice were injected with either canine peripheral blood mononuclear cells (PBMCs) or cultured NK cells for 2 or 3 weeks. Data were then collected on changes in mice body weights, disease severity scores, and survival rates. Histopathological and immunohistochemical evaluations were also performed. All mice injected with canine PBMCs died within 45 days after injection. Severe clinical signs were caused by GVHD. The histopathological and immunohistochemical evaluations showed that mice injected with canine PBMCs had multiple lesions, including necrosis in their lungs, livers, kidneys, and stomachs, and the injected cells were present around the lesions. By contrast, no mice injected with cultured NK cells without removing the CD3+TCR– cells exhibited any clinical abnormalities. Moreover, they all survived the 90‐day experimental period without exhibiting any histopathological changes. Accordingly, the results of this study suggest that canine NK cells do not cause significant side effects such as GVHD and allogeneic NK cells can safely be used for cancer immunotherapy in dogs. [ABSTRACT FROM AUTHOR]